Key Factors Inhibiting Growth of the Global Lactose Intolerance Treatment Market Throughout 2017 - 2025

Lactose intolerance is a gastrointestinal condition developed in patients with a low activity level of
the lactase enzyme. Lactase is responsible for breakdown of lactose, a type of sugar found in all
dairy products. Symptoms of lactose intolerance are at times very painful and even embarrassing
due to flatulence. Symptoms are usually seen only after consumption of dairy products. They
include abdominal pain, flatulence, bloating, cramps, and diarrhea. In a study on lactose intolerance
conducted by Engage Health in 2008, 82% of patients reported that symptoms of lactose intolerance
affect their daily social routine.
Report Overview and TOC @ https://www.transparencymarketresearch.com/lactose-intolerancetreatment-market.html
Lactose intolerance is either hereditary or due to factors such as presence of intestinal parasites,
chemotherapy, side-effect of penicillin, post-surgery effect, less or no consumption of dairy
products, and hormonal changes during pregnancy. The heredity form of lactose intolerance is
generally found in people in whom consumption of dairy products is limited, for instance, people in
countries of Africa and Asia. The diagnosis of lactose intolerance is done usually after the frequent
observation of symptoms. The relation between onset of symptoms and consumption of dairy
products has been recorded for the diagnosis of lactose intolerance. Furthermore, hydrogen breath
test, which is done to diagnose issues with lactose digestion, is one of the confirmatory tests. Other
tests such as stool examination in order to check presence of parasites, blood test for celiac disease,
and intestinal biopsies need to be done to detect the presence of lactose intolerance. High
prevalence of lactose intolerance is observed among people that consume dairy products in low
quantities. A few countries where lactose intolerance is observed are China, Japan, Italy, India, and
Brazil. It is estimated that nearly 80% of the people in China suffer from lactose intolerance. In the
U.S., approximately 60 million people are suffering from lactose intolerance. The number of people
suffering from lactose intolerance worldwide is estimated to be around one billion.
Request brochure @ https://www.transparencymarketresearch.com/sample/sample.php?
flag=B&rep_id=31331
Major factors responsible for rise in the population suffering from lactose intolerance are lifestyle
changes, unhealthy eating habits, and low production of dairy products. The treatment of lactose
intolerance is consumption of lactase enzyme in the form of drops or tablets. The treatment is
usually taken in order to avoid social embarrassment. In case of hereditary lactose intolerance,
consumption of lactase enzyme or lactose-free foods is the only option to avoid symptoms. Also,
increasing disposable income in Asia Pacific and Middle East & Africa will accelerate the growth of
purchase of synthetic lactase enzyme in this regions. Factors such as ignorance of symptoms by
considering those as usual digestive issues and low cost of products used in treating digestive
system restrain the market for lactose intolerance.
For Specific and Customized requirements @
https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=31331
In terms of revenue, North America and Europe dominate the global lactose intolerance market.
Around 60 million people in North America suffer from lactose intolerance. Growth of the lactose
intolerance market in the region is attributable to food trends followed by individuals in this region.
Latin America, Middle East & Africa, and Asia Pacific are emerging markets for lactose
intolerance, due to low availability of dairy products in these regions. These two regions possess
high potential for use of lactase enzyme to overcome lactose intolerance.
Prominent players operating in the global lactose intolerance market are Ritter Pharmaceuticals.,
McNeil Nutritionals, LLC, Gelda Scientific, National Enzyme Company, Guardian Drug Company,

Deerland Enzymes, Inc., and Roche Diagnostics.
Pre Book full report @ https://www.transparencymarketresearch.com/checkout.php?
rep_id=31331&ltype=S
About Us
Transparency Market Research (TMR) is a global market intelligence company providing business
information reports and services. The company’s exclusive blend of quantitative forecasting and
trend analysis provides forward-looking insight for thousands of decision makers. TMR’s
experienced team of analysts, researchers, and consultants use proprietary data sources and various
tools and techniques to gather and analyze information.
TMR’s data repository is continuously updated and revised by a team of research experts so that it
always reflects the latest trends and information. With extensive research and analysis capabilities,
Transparency Market Research employs rigorous primary and secondary research techniques to
develop distinctive data sets and research material for business reports.
Contact
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Sales: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/
Blog: http://www.tmrblog.com/